Prostaglandin-Endoperoxide Synthases
"Prostaglandin-Endoperoxide Synthases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor.
| Descriptor ID |
D011451
|
| MeSH Number(s) |
D08.811.600.720 D08.811.682.690.708.715
|
| Concept/Terms |
Prostaglandin-Endoperoxide Synthases- Prostaglandin-Endoperoxide Synthases
- Prostaglandin Endoperoxide Synthases
- Synthases, Prostaglandin-Endoperoxide
- Prostaglandin-Endoperoxide Synthase
- Synthase, Prostaglandin-Endoperoxide
- Cyclooxygenase
- Cyclooxygenases
- Fatty Acid Cyclo-Oxygenase
- Cyclo-Oxygenase, Fatty Acid
- Fatty Acid Cyclo Oxygenase
- Hydroperoxide Cyclase
- Cyclase, Hydroperoxide
- PGH Synthase
- Synthase, PGH
- PGH2 Synthetase
- Synthetase, PGH2
- Prostaglandin Cyclo-Oxygenase
- Cyclo-Oxygenase, Prostaglandin
- Prostaglandin Cyclo Oxygenase
- Prostaglandin Cyclooxygenase
- Cyclooxygenase, Prostaglandin
- Prostaglandin Endoperoxide Synthetase
- Endoperoxide Synthetase, Prostaglandin
- Synthetase, Prostaglandin Endoperoxide
- Prostaglandin G-H Synthase
- G-H Synthase, Prostaglandin
- Prostaglandin G H Synthase
- Synthase, Prostaglandin G-H
- Prostaglandin H Synthase
- Synthase, Prostaglandin H
- Prostaglandin H2 Synthetase
- Synthetase, Prostaglandin H2
- Prostaglandin Synthase
- Synthase, Prostaglandin
- Prostaglandin Synthetase
- Synthetase, Prostaglandin
- Arachidonic Acid Cyclooxygenase
- Cyclooxygenase, Arachidonic Acid
- Cyclo-Oxygenase
- Cyclo Oxygenase
|
Below are MeSH descriptors whose meaning is more general than "Prostaglandin-Endoperoxide Synthases".
Below are MeSH descriptors whose meaning is more specific than "Prostaglandin-Endoperoxide Synthases".
This graph shows the total number of publications written about "Prostaglandin-Endoperoxide Synthases" by people in this website by year, and whether "Prostaglandin-Endoperoxide Synthases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 3 | 0 | 3 |
| 1999 | 2 | 3 | 5 |
| 2000 | 1 | 2 | 3 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 4 | 5 |
| 2003 | 8 | 3 | 11 |
| 2004 | 1 | 4 | 5 |
| 2005 | 4 | 4 | 8 |
| 2007 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostaglandin-Endoperoxide Synthases" by people in Profiles.
-
Cyclooxygenase reaction mechanism of PGHS--evidence for a reversible transition between a pentadienyl radical and a new tyrosyl radical by nitric oxide trapping. J Inorg Biochem. 2011 Mar; 105(3):356-65.
-
Cyclooxygenase reaction mechanism of prostaglandin H synthase from deuterium kinetic isotope effects. J Inorg Biochem. 2011 Mar; 105(3):382-90.
-
Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study. Int J Gynecol Cancer. 2005 Jul-Aug; 15(4):646-56.
-
Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Clin Cancer Res. 2005 Mar 01; 11(5):1999-2007.
-
Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate. J Exp Ther Oncol. 2004 Dec; 4(4):317-25.
-
Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic hepatitis C: a short term pilot study. Cytokine. 2004 Sep 21; 27(6):159-65.
-
Eicosanoid metabolism in squamous cell carcinoma cell lines derived from primary and metastatic head and neck cancer and its modulation by celecoxib. Cancer Biol Ther. 2004 Sep; 3(9):847-52.
-
Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray. Int J Mol Med. 2004 Jul; 14(1):43-53.
-
Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Aliment Pharmacol Ther. 2004 May 15; 19(10):1051-61.
-
Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells. J Lipid Res. 2004 Jun; 45(6):1030-9.